El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

878658.pdf (909.62 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2022-07-11

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/224761

The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed a prospective cohort study

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1111/jth.15797

Resum

Background: A hypercoagulable state is not associated with development of portal vein thrombosis in cirrhosis, as we previously demonstrated. However, some groups demonstrated elevated levels of inflammatory markers and activation of hemostasis in the portal vein (PV) compared to posthepatic veins, but because the liver is involved in clearance of these markers, we hypothesize that interpretation of these data is not straightforward. Aim: To determine whether the PV has particular proinflammatory/hypercoagulable characteristics by comparing plasma sampled in the PV, hepatic vein (HV), and the systemic circulation. Methods: Plasma samples from 51 cirrhotic patients with portal hypertension undergoing transjugular intrahepatic portosystemic shunt placement, were taken from the PV, HV, and jugular vein (JV). Markers of inflammation (lipopolysaccharide, tumor necrosis factor-α, interleukin-6, thiobarbituric acid-reactive substances), neutrophil-extracellular-traps (cfDNA, MPO-DNA), endothelial damage (von Willebrand factor [VWF]), and hemostasis were determined and compared among the three vascular beds. Results: Markers of inflammation were slightly, but significantly higher in the PV than in the HV and systemic circulation. VWF and markers of hemostasis were modestly elevated in the PV. Levels of multiple markers were lower in the HV compared with the PV and systemic circulation. Higher model for end-stage liver disease score was associated with a more prothrombotic state in all three sample sites. Conclusion: In contrast to published studies, we did not detect a clear proinflammatory or prothrombotic environment in the PV of cirrhotic patients. Many markers are lowest in the HV, indicating that the low levels of these markers in the HV, at least in part, reflect clearance of those markers in the liver.

Matèries

Coagulació sanguínia, Cirrosi hepàtica, Inflamació

Matèries (anglès)

Blood coagulation, Hepatic cirrhosis, Inflammation

Citació

Col·leccions

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

DRIEVER, Ellen g., MAGAZ MARTÍNEZ, Marta, ADELMEIJER, Jelle, TURON, Fanny, BAIGES AZNAR, Anna, OLIVAS, Pol, PÉREZ CAMPUZANO, Valeria, HERNÁNDEZ GEA, Virginia, BLASI IBÁNEZ, Annabel, GARCÍA PAGÁN, Juan-carlos, LISMAN, Ton. The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed a prospective cohort study. _Journal Of Thrombosis And Haemostasis_. 2022. Vol. 20, núm. 9, pàgs. 2075-2082. [consulta: 2 de gener de 2026]. ISSN: 1538-7933. [Disponible a: https://hdl.handle.net/2445/224761]

Exportar metadades

JSON - METS

Compartir registre